ReleaseWire

App based on the popular show set to gain huge popularity in a short span

Growing up can be scary – especially for children and teens who suffer from Obsessive Compulsive Disorder (OCD). That's one of the reasons a new film "UNSTUCK: An OCD Kids Movie," is screening in therapy and community centers across the U.S. and Canada for International OCD Awareness Week, (October 8 through 14). The 23-minute documentary examines the often-misunderstood mental health disorder and shows how six kids are facing – and fighting – some of their worst fears.

R&D pipelines and new product launches reached record levels last year with sustained growth throughout the pandemic creating very positive figures for 2021. This is according to a new report that showed 5,500 planned new clinical trials began in 2021, a 14% increase on the year before. Not only that but the total volume of products that were actively being developed last year peaked at more than 6,000. This is a huge increase on previous years - for example, it's 68% more than in 2016. The report also revealed that emerging pharma companies are increasingly having an influence over new pipelines and projects. In 2021, new companies were responsible for 65% of the molecules in the R&D pipeline. In 2016 this figure was below 50%. In fact, almost all the indicators are up when it comes to pharma R&D, which shows just how much the life sciences have expanded over the past couple of years.

There are many more opportunities in biotech than there have ever been today. This is, in part, thanks to the many start-ups that have begun to dominate the sector, bringing agile working models as well as innovative products and services. Newly founded companies provide options for different ways of working, and moving away from the stereotypes that might have dominated the industry in the past. For those who are willing to take on the uncertainty that can come with working for such a new company, there are options in biotech that go beyond academia or the big pharmaceutical or biotech giants. Biotech start-ups can offer a lifestyle change, and may be much more likely to hire on the basis of aptitude and enthusiasm, as opposed to a list of credentials that has been set in concrete. The number of start-ups in biotech is also rising by the week so the range of opportunities available is getting increasingly broad.

Global healthcare advisory and technology company Alira Health has taken steps to strengthen its operations with a key acquisition. The company announced in April of this year that it had acquired Sourcia, which is a Contract Research Organization (CRO) that delivers services for Phase I to Phase IV clinical trials. Sourcia was established in 2012 and the business' focus is on medical devices, biotech and digital therapeutics. It is headquartered in Europe - The Netherlands - and has offices in many different European locations, including Munich in Germany. The integrated outsourcing model that Sourcia provides for clients to manage clinical trials with greater efficiency and trust is well established - and it is this that motivated Alira Health to make Sourcia part of its group with the acquisition. The team at Sourcia is also renowned for being innovative and very experienced and, as Sourcia is such a strong player in the European CRO market, it will give Alira Health's clinical operations a considerable boost.

Construction is an industry that has weathered the storm over the past few years and now there are green shoots emerging. In states such as Ohio, commercial real estate prices have reached new highs and expansion is forecast across all areas of the sector. This includes growth trends in water supply, transportation and S&WD. Of course, there have been some more challenging trends too, including the labor shortages that have affected the construction sector nationwide, as well as the supply chain issues that many industries have struggled with. Another key trend is the growth in demand for skilled construction workers - job postings are up 43%, which means that the need for workers is currently higher than the supply. This is a trend that looks set to continue for some time, as there is a mismatch between the skill sets that many workers have available and the qualification levels required. Construction activity, especially in areas such as mining in locations like Ohio, looks set to continue to grow throughout the year.

Atlanta, Georgia is to be the location of a new enterprise solutions hub for the biotech company Moderna. The business has revealed that the new hub will be similar to the one that it opened in Poland in 2021 and will deliver a number of different functions, including finance, procurement, human resources and digital. Over the next couple of years, the US-based premises will employ up to 200 people and is part of Moderna's overall goal to establish itself with centralized enterprise solutions hubs worldwide. The Atlanta location is due to open in the second quarter of 2022 and is a firm indication of how important ongoing expansion is at Moderna. The company experienced a year of incredible growth last year and the need to support its biotech talent with robust business service activities has been underscored by its expansion - it's likely that this will be just the first step towards further growth at Moderna.

Drones are being increasingly welcomed into many sectors due to their convenience and usefulness. Although New York has so far seen only limited use for this tech when it comes to façade inspections (due to restrictive local ordinances) that is all about to change as a new report has identified how drones could be used more when it comes to façade engineering inspections in the future. The report from the New York City Department of Buildings identifies drones as a useful tool. It says that, when combined with traditional hands-on examinations, the drones could potentially make future inspections more thorough and comprehensive. Right now, there are significant restrictions in place when it comes to flying drones over New York City - and only specific locations where it's legal for them to take off and land - but this could soon be about to change if the recommendations of the Department of Buildings report are widely accepted.

Digital capabilities are being pushed further up the agenda for organizations across industries, as the global recovery continues. From driving innovation to uncovering key marginal gains, digitization has a lot to contribute to progress, especially in a sector like manufacturing. Data analytics is potentially especially valuable but there are few organizations that are really optimizing the opportunities that exist in data and advanced analytics. These range from simplifying supply chain relationships to streamlining costs. Manufacturers today are beginning to realize the value of data analytics when it comes to designing the factories of the future. While most would acknowledge that they lack data fluency, there is also a clear and pressing need to start adapting environments so that data can have a real, tangible impact on the production line. With the right tools and the right support factories of the future can be leaner, more productive and better-resourced thanks to the impact that data analytics can potentially have.

Despite the obvious supply chain issues of the past 12 months, there has been positive news for US construction, with spending surging more than 8% on previous figures at the start of this year. Outlays on single-family homebuilding and private nonresidential structures provided a particular boost to the numbers, which showed an increase in both the figures from the year before as well as those for December. Although the rise in spending is positive, the reality of higher prices for building materials is obviously still having an impact. This is especially so with respect to materials such as framed lumber. Spending on public construction projects also saw a small increase of 0.6% during the same time period. In terms of local and federal spending on construction, the numbers couldn't be more different, with outlay on federal projects increasing by 13.8% while local and government construction projects saw a reduction in spending of 0.5%.

Multinational pharmaceutical firm Bristol Myers Squibb has created a single R&D research campus in San Diego, California that will consolidate all its teams in the area. The move by the firm will result in a 427,000 square foot complex where the company will be able to host all its research talent in the region. The idea behind the consolidation is to "foster a flexible working ecosystem" and help to boost collaboration among all those who are working on R&D for the pharmaceutical company in this part of the country. The building, which has some impressive space and features, is also part of a talent retention strategy at Bristol Myers Squibb, and a push to find the best people to come and apply their minds on the new campus. The new facility is part of a wider development that has a wealth of facilities, including a wellness and fitness center and an organic eatery.

Biopharmaceutical clinical research organization, Celerion, has this year announced a considerable expansion that involves adding extensive research capacity and services. The company is adding significantly to the resources that it has for early phase clinical research, including upgrading pharmacy compounding suites and opening a new Screening and Return Center. This new capacity comes in the form of development at existing sites, including a new 40,000 square foot facility in Phoenix, Arizona that will add 350 beds to the company's capacity. The new facility is not just about expanding resources but has also been designed with participant experience in mind. Expanded pharmacy capabilities are intended to provide a fast and cost-effective way for clients to begin clinical trials, without the need for extensive CMC investment in the early stage of development. Celerion is renowned for its combination of clinical operations and medical expertise, pioneering new options for its clients in drug development.

AiM Medical Robotics is well known for being a leading developer of MRI-compatible intraoperative robotics for neurosurgery. The innovative company is taking huge strides in the development of neurosurgery thanks to the work that it has done with precision robotics. This includes improving outcomes for patients with functional brain disorders who are going through the process of neurosurgery. Some of the conditions that benefit from the company's research include epilepsy and Parkinson's. It has now been announced that AiM Medical Robotics is going to be returning to the Life Science Intelligence (LSI) USA '22 Emerging Medtech Summit as a presenting company. This is the event's third year and the summit has become renowned for providing an annual glimpse into the future of life sciences technologies and the most up-to-date market intelligence. AiM Medical Robotics will be a great fit for the summit as a presenting company.

The market for pharmaceutical R&D expanded significantly in 2021, its valuation increasing to $183.62 Bn. The US is currently the largest market for pharmaceutical R&D in the world and accounts for almost half of spend. In recent years costs in the R&D market have risen thanks to factors such as greater technological complexity and greater specificity in disease targets. However, small firms tend to receive access to knowledge and resources that are designed to help ensure a more equal playing field. The market overall is thriving and forecasts indicate that it will expand to a valuation of $289.64 Bn by 2027. One of the big trends to define the pharmaceutical R&D market recently has been contract manufacturing outsourcing for both clinical and commercial stage manufacturing. This is being driven significantly by the necessity of cutting-edge processes and production technologies.

A-1 Hydro. / Safe Wash Technologies, the industry leader in providing quality eco-friendly detergents to keep commercial, industrial, and recreational equipment and facilities clean, is pleased to be offering a full line of environmentally-friendly power washer soaps to businesses in New York City, Medford, Bridgeport, Brooklyn, Norwalk, New Windsor, and the surrounding areas. No matter what needs to be cleaned or how large it is, their range of pressure washer soaps will help get the job done right as well as fast in an environmentally friendly manner.

Antibiotics have come to underpin evolution in human healthcare - and the market is set to grow dramatically in the coming years. Increasing numbers of bacterial infections have meant demand for antibiotics has soared, whether that is treating skin infections, Urinary Tract Infections or something like tuberculosis. Infectious diseases have also been driving the need for greater pharma R&D to find new solutions to diseases such as pneumonia, malaria and lower respiratory infections. This increasing disease burden is making it even more important for governments to invest in vital R&D initiatives to help fuel the development of novel antibiotics and improve the regulatory environment to speed up research and approvals. With all this under the spotlight, it's no surprise that forecasts for market growth are high - the global antibiotics market size is set to increase to $45.4 billion by 2028. This represents a significant increase from the value of $38 billion in 2021.

Challenges have been plentiful for the construction sector over the past year, whether they relate to politics or the pandemic. However, not every part of the industry has been negatively affected, in fact, some have gone on to thrive. As a result, there are a lot of construction projects to watch in 2022. Progress on the ground-breaking HS2 in the UK, for example, has gathered momentum and looks set to speed ahead in 2022, especially at the Old Oak Common site, the only stop along the HS2 in the capital. Sizewell C is a large-scale nuclear energy project that could be one of a number of nuclear developments to receive Treasury funding. According to EDF, construction at Sizewell C could begin before 2024. The former US Embassy at 30 Grosvenor Square in London is going to be the site of another major piece of construction. The £400 million project will convert the former embassy into a 139-room luxury hotel that will be part of the Rosewood group.

The East Coast is a key hub for the biotech industry and some major pharmaceutical and life sciences organizations and institutions are located in this part of the US. For a biotech recruiter that makes this a particularly important location, especially as hiring in this location is forecast to remain strong throughout 2022. Massachusetts is a prime example of the strength of East Coast biotech, as it's a state with robust collaboration between government, industry and academia, as well as large waves of talent entering the sector here, including a 50% increase in graduates from biotech programs in the past 10 years. New York is also a key contributor to the strength of East Coast biotech recruitment, thanks to 50+ hospitals, 9 academic medical centers and a $1 billion initiative to create 40,000 new jobs and establish the city as a global leader in the industry. Then there is New Jersey, which is home to 14 of the top 20 pharmaceutical companies in the country and 3,200 life sciences companies.

Remote clinical operations present an innovative opportunity for the evolution of life sciences into a more versatile, digital age. During the pandemic, Trans Perfect in partnership with Innovaderm used Trial Interactive tech to make a significant contribution to partner organizations seeking to find new treatments to COVID-19 and to help support further research. Trial Interactive is a connected eClinical experience that is designed to make improvements in a number of key areas, including compliance, speed and quality across site detection, selection and activation. Remote clinical trials were achieved by giving customers access to Trial Interactive's Study Document Collaboration solution by integrating tailored remote monitoring rooms. Now, Trans Perfect and Innovaderm are looking to scale the deployment of Trial Interactive to offer the opportunity of remote clinical operations on a much broader basis. The two companies have been in a long-standing collaboration that began with language translation services many years ago. Today, together they have an opportunity to make an impact with remote clinical operations on a much bigger scale.

Advanced analytics is a fast-expanding market and one that continues to accelerate as more and more companies start to buy into the use of greater analytics and AI solutions. Forecasts indicate that the market is set to grow from $33.8 billion in 2021 to $89.8 billion by 2026. That represents a Compound Annual Growth Rate of 21.6%. Some of the factors behind the significant increase in the size of the data analytics market include the increasing use of AI and ML technologies to generate real-time customer insights. The impact of the pandemic has been substantial in terms of driving companies to start using this technology, with the goal of creating more effective strategies to achieve goals such as greater engagement via digital channels, as well as supporting employees through ongoing disruption and managing challenging moments in supply chains. As more organizations reap the benefits of advanced analytics, the global market will continue to grow.

Glass is well established as a popular construction material and looks set to become even more of a magnet for investment going forward. A new report has identified the glass façade market as one set for significant growth over the next six years. According to the latest forecasts, the market is going to reach a value of $92.6 billion by 2026, which represents a Compound Annual Growth Rate expansion of 3.9%. Glass façades have become a first choice in construction due to the qualities that they bring to a build, including energy efficiency, cost-effectiveness and aesthetics. Tempered glass is set to see a particularly impressive rise in growth - this material allows building design to make the best use of natural light and reduce energy consumption so it is on-trend with many of the sustainable initiatives happening right now. This and other factors, such as the rise in raw energy costs, are going to work to drive up the value of the market by 2028.

Regenerative medicine is developing an increasingly visible reputation in healthcare, both among patients and professionals. This innovative sector has enormous potential for changing outcomes for patients thanks to treatments such as cell-tissue therapeutics and products like exosomes and Chimeric antigen receptor T cell therapy. Patients are becoming increasingly aware of, not just the risks that are associated with regenerative medicine, but the advantages too. As a result, forecasts for the increase in the size of the regenerative medicine market are substantial, especially as a wider range of products is increasingly being launched to help prevent complications in patients. One study has found that by 2028 the market for regenerative medicine is likely to be worth $12.9 billion. A particular focus for those operating in regenerative medicine has been the need to spread awareness so that patients can make informed decisions that lead to better outcomes where treatments are concerned.

It's not breaking news to say that the market for cloud infrastructure is still growing at a very impressive rate. Even as the market starts to mature, the likes of Amazon, Google and Microsoft are seeing incredible increases in revenue, especially given the impact of mass remote working over the past year. Google and Microsoft are growing at around 40% a quarter, while Amazon is just under that. Overall, the market has seen a huge increase in just a single year with a spike of $50 billion in business in just 12 months. Despite an overall increase in the market, the big three players have retained a fairly similar market share over the past year. Amazon remains the largest player with a 33% share, while Microsoft has 21% and Google has 10%. This market share isn't forecast to change that much, even though the cloud infrastructure market will continue to grow at a significant pace.

Businesses of any scale and size can seek the assistance of the Robert O. Mable Agency. They assist their business clients in identifying and investing in the perfect insurance coverage as per their unique requirements and concerns.

Over the past year, we have begun to see many talented people moving roles to look for new challenges. In 2022, those in jobs such as forensic engineering could find that they have even more to look forward to via a new employer, as these are set to be some of the top 10 paying jobs of the year. This data comes from a January 2022 report that identified how skills shortages in many areas are creating significantly increased demand.

The demand for clinical operations staff has soared during the pandemic and in most locations, this has created some serious skills shortages. As a result, many US hospitals have turned to overseas hires to fill the gaps. One agency recruiting clinical operations staff from overseas to place in US hospitals saw demand surge from just 800 places a year pre-pandemic to 4,000 today.

The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way that the vaccines have worked for COVID has been to teach the body to target the virus - now the same approach is being focused on cancer cells too. The company behind the vaccine is BioNTech, which is the German pharmaceutical business that partnered with Pfizer in 2020 to produce the first vaccine that was authorized for use against COVID in the US.